Metabolic syndrome in patients with hematological diseases.
about
Naotaifang extract treatment results in increased ferroportin expression in the hippocampus of rats subjected to cerebral ischemia.Adverse health events and late mortality after pediatric allogeneic hematopoietic SCT-two decades of longitudinal follow-up.Chemotherapy alone or HSCT after reduced-intensity conditioning for patients with malignant hematologic diseases are not associated to metabolic syndrome: a cross-sectional observational study.Cardiovascular Risk Factors after Childhood Cancer Treatment Are Independent of the FTO Gene Polymorphism?
P2860
Metabolic syndrome in patients with hematological diseases.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Metabolic syndrome in patients with hematological diseases.
@en
type
label
Metabolic syndrome in patients with hematological diseases.
@en
prefLabel
Metabolic syndrome in patients with hematological diseases.
@en
P2093
P2860
P356
P1476
Metabolic syndrome in patients with hematological diseases
@en
P2093
Claudio Annaloro
Francesco Onida
Giorgia Saporiti
Giorgio Lambertenghi Deliliers
P2860
P304
P356
10.1586/EHM.12.35
P577
2012-08-01T00:00:00Z